Heparin probe finds U.S. tie to Chinese plant
The Wall Street Journal (subscription required), February 15, 2008
Baxter International Inc.'s investigation into the cause of deaths and allergic reactions linked to its blood-thinner heparin is focusing on variations in batches of the active ingredient for the drug, most of which were supplied by a Chinese manufacturing facility co-owned by a Wisconsin company. Baxter said the active ingredient for its heparin was supplied by Scientific Protein Laboratories LLC, a Waunakee, WI, company with a manufacturing facility there and a joint-venture operation called Changzhou SPL in Changzhou, China.
Most Viewed
Most Emailed
- Primary Care Docs Average More Hospital Revenue Than Specialists
- How Chargemaster Data May Affect Hospital Revenue
- $6.4B Henry Ford, Beaumont Merger Failed on Cultural Hurdles
- House Lawmakers Grill CMS Over Health Exchange Navigators
- 69% of Employers Plan to Offer Healthcare Coverage After 2014
- ED Physicians Key to Half of Hospital Admissions
- Insurer's App Aims to Lower Healthcare Costs, Securely
- Fortunately, Angelina Jolie Isn't On Medicare
- Don't Let Nurses Sink Your Bottom Line
- Q&A: Catholic Health Initiatives' New Senior VP for Capital Finance
